Research on Immune Response in Inflammatory Bowel Disease

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Recruiting Observational Study
Inflammatory Bowel Disease Ulcerative Colitis Chrohn's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 75
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Who this trial is looking for

This trial is looking for patients with Crohn’s disease or ulcerative colitis. Participants will help researchers understand how the immune system causes inflammation in the digestive tract without receiving any experimental treatments.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 0 and 75 years old.
  • I have been diagnosed with Crohn’s disease or ulcerative colitis.
  • I have symptoms of inflammatory bowel disease.
  • I have been told I have a genetic syndrome linked to inflammatory bowel disease.
  • I can give consent to participate.

You may not be able to join if

  • I do not meet the inclusion criteria.
  • I have any medical condition that could make joining the study risky.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system controls inflammation in the gastrointestinal tract (stomach and intestines)-specifically, how lymphocytes (a type of white blood cell) function in inflammatory responses. This protocol does not involve any experimental treatments. Patients between the ages of 0 and 75 years of age wit…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: 1. Patients with a verifiable diagnosis of Crohn s disease, ulcerative colitis, or IBD known to be associated with a co-existing condition and which is supported by characteristic clinical features, radiographic or endoscopic findings, or consistent histopathologic mucosal …
Contacts

Sandra M Maxwell, R.N.

(240) 627-3078

maxwells@mail.nih.gov

CONTACT

Ivan J Fuss, M.D.

(301) 761-7091

ifuss@niaid.nih.gov

CONTACT